Tyratech Share Discussion Threads

[liquid millionaire] 25/2/2015 07:42

25 February 2015

TyraTech, Inc.

("TyraTech" or the "Company")

Lloyds and Day Lewis Pharmacy listings

Vamousse(R) Advertising and Marketing Award

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is delighted to announce new listings for its Vamousse(R) Head Lice Treatment and Protective products with Lloyds Pharmacy and its Treatment product with Day Lewis Pharmacy in the UK.

Day Lewis, which began stocking the Vamousse range in January 2015, is the largest independent pharmacy chain in the UK with more than 200 outlets. Lloyds, a well respected household name at the forefront of community pharmacy, has a distribution network of more than 1600 outlets in the UK and is expected to commence stocking Vamousse products from March 2015.

Vamousse - broadening the distribution network

With distribution already established in Boots, Superdrug, Sainsbury's, Tesco and Rowlands, the addition of Lloyds and Day Lewis gives Vamousse a comprehensive UK distribution platform for 2015. Increasing the physical distribution points is particularly important for head lice products that tend to be emergency purchases. Customers need to be able to find the products close to home in order to solve their head lice problems as fast as possible.

Vamousse - advertising and marketing campaign award

TyraTech is particularly pleased that the Vamousse brand has won the Independent Community Pharmacy (ICP) magazine 'Pharmacy Product Of The Year - Best Advertising Campaign' award. This prestigious award is voted for by practicing pharmacists. The award recognises and reflects the strong awareness and engagement generated by the Vamousse marketing campaign amongst pharmacists and pharmacy staff. Their awareness and recommendation of the Vamousse Treatment and Protective range are key ingredients in the commercial success of these products.

Bruno Jactel CEO of TyraTech commented:

"We are delighted to announce these new listings for our Vamousse treatment and preventative products, taking us initially into more than 1300 new distribution points in the UK from March 2015.

"I am very pleased with our achievements in the UK marketplace in the eight months since the launch of the Vamousse product range. We are confident of continued positive developments as our comprehensive UK distribution platform reaps the benefits of our highly engaging and effective marketing campaign."

[michaelsadvfn] 25/2/2015 07:20

News for the doubting Thomases.

This is going through the roof today........

[michaelsadvfn] 20/2/2015 11:00

michaelsadvfn 13 Feb'15 - 05:45 - 1623 of 1626 1 0 edit

I made close to a 6 figure sum buying these at 4.5 - 5p before they shot up to over 22p last year and expect to make close to another 6 figure sum buying again at these prices.

If you are not already aware, you can buy TYR shares now at under 4.5p and flip them into TYRU 12 months from now for a very tidy profit, assuming all things stay the same.

As ever, most folk just can't see a good investment when it's staring them in the face. The time to buy shares is when no one else is buying. Now where have I heard that before?

Q.E.D.

[al h] 20/2/2015 10:56

Something going on ... or maybe nothing, guess only the insiders know

[bsimm] 17/2/2015 05:28

Response received from Home Depot.

This was touted as a major win for Tyratech. The market has yet to be advised.

...................................

Dear Mr.######,

Home Depot does not carry any of the products that you listed. The
Upland, California store researched the products; advised that Raid, Hot
Shot, Ortho and Spectracide are the brands carried in our store.

Your customer care reference number is ########.

If I may be of further assistance, please contact me on the toll free
number below or simply reply to this email .

Thank you for choosing the Home Depot.

......................................

Terminix Ultimate Protection Crawling Insect Killer
Terminix Ultimate Protection Flying Insect Killer
Terminix Ultimate Protection Stinging Insect Killer

.......................................

Petition Share Prophets

[michaelsadvfn] 13/2/2015 05:45

Seems to be a very expensive product based on sodium chloride /salt/....

Please don't go down that road again FFS...and don't start quoting what's on the label. It has been discussed at length in the past and to be quite honest I have no intention of getting into that discussion again.

Perhaps ask yourself why Bruno Jactel would leave his senior position at Merial to take over as CEO?



If I were you I would concentrate on what he has achieved in the last 2 years instead of quoting what losses they incurred as far back as 2007.

I made close to a 6 figure sum buying these at 4.5 - 5p before they shot up to over 22p last year and expect to make close to another 6 figure sum buying again at these prices.

If you are not already aware, you can buy TYR shares now at under 4.5p and flip them into TYRU 12 months from now for a very tidy profit, assuming all things stay the same.

As ever, most folk just can't see a good investment when it's staring them in the face. The time to buy shares is when no one else is buying. Now where have I heard that before?

[michaelsadvfn] 02/2/2015 07:27

Nice update.

With the share price down by a third on this time last year there is plenty of room for a rerating here. I can't quite understand why this stock is so out of favour.

[michaelsadvfn] 18/1/2015 06:48

Not really 'stuck' with them as I can sell them when I want, I just can't convert them for a year. I'll be hanging on to this lot until I can convert.

All we need here is sentiment to change but who knows when that will happen. It changed last time on a Daily Mail article and the company has done well since so at this level I believe there is money to be made.

[gemferret] 16/1/2015 08:23

Michael

With that route I thought it meant you are stuck with them until the next yearly transfer period and can't sell them on a rise or drop.

I recall similar advice at 10/12p re those bargains but the buyers have (if I'm right) been stuck not being able to sell and so have to take the full paper loss, instead of having the option to sell re the trend or news.

If the thought process is buy and forget, then that's fine.

I think such circs are unusual and the spilt and circs around that keeps many away as they don't understand it.

[michaelsadvfn] 15/1/2015 11:39

Well after watching TYRU rise 20% today and TYR do nothing I picked up 100k TYR at silly prices.

The current share price is below the price before half the world started selling VaMousse so even more of a bargain than it was a year ago.

Ta very much Mr. Market.

[haroldthegreat] 13/1/2015 21:14

i still havent had one request for vamousse! hope someone buys it before the expiry date. so much for the advertising campaign .

[gemferret] 13/1/2015 11:40

Having checked the figures there is no way they can avoid find raising under the current revenue rates and recent reported circs.

Note they have been careful to say that they have enough funds to cover the commercial launch, NOT the day to day costs.

So it all points to around 50 million shares dilution around the 4/5p mark.

That assumes no commercial deals with majors on products.

So I'll be lurking waiting for that event.

I do however think the MC is nuts v the potential and one of the biggest disparities on any AIM.

That's why I'm lurking and watching carefully. H2 I believe is the potential start of the game changing here, if things go well.

[gemferret] 10/1/2015 11:23

Now do you believe me re my historic posts.

This was always going to be the outcome based on the news they have released in the past.

They warned delays in launch can significantly impact near term revenues, and it was easy to spot to Vamousse delay in the UK.

Other products currently launched are in general relevant to the mid Spring through Autumn time and we were heading into winter.

So the Novartis issue wasn't going to be a lot different.

Their cash situation looks like they need a fund raise regardless of what they said, I fail to see with their cash burn how they can avoid funds needed.

No serious volumes yet the market seems happy to destroy the share price perhaps accommodating funds for any fund raise at much more favourable levels.

Ridiculous MC compared to the product potential.

I have been entirely unimpressed with their vamousse advert. I finally saw it for the first time on the History channel. A really popular Mums and kids channel that one, and they had chopped it down to just a few seconds.

They must be in cash preservation mode.

The main trick of non chemical products which is a big plus is not being mentioned in adverts. That too me is a stupid mistake and a point they should push.

The fact is they have limited cash and can't push just yet. Too many chiefs and salaries to pay.

Terminix/Envance/AMVAC which looked hugely promising seems to be delivering nothing at this time.

2015 should be the turn but I'll wait for the fund raising or a material announced change in fortunes that show that is not happening.

This is a sleeper and could multiply rapidly if the team get it right.


Was it share prophets that were pushing it pre this slump with daft H2 figures? I did warn what they were up too. Attracting attention to dump their shares no doubt.

[techair] 07/1/2015 18:36

Michaelsadvfn - it is all relative. Both these 2 Herberts are on £300k pa plus options for the last few years and what do we have to show for it? Broken promises imho

[michaelsadvfn] 05/1/2015 07:01

jxman 2 Dec'14 - 15:10 - 1604 of 1609 0 0

Same old story here. Been the same for years. Incompetent management.

Was Bruno Jactel sacked by Merial then?.......

Mr. Jactel spent 12 years at Merial Limited ("Merial"), the US$2.6 billion revenue generating Animal Health subsidiary of the Sanofi Group, most recently as combined Chief Strategy Officer and Chief Marketing Officer. As Head of commercial operations in Europe, Mr. Jactel developed successful growth strategies in both OTC and professional channels. He was further responsible for global marketing, brand management and enterprise and franchise strategy, in addition to being a co-chair on the R&D steering committee. During this time, Merial built the most successful consumer brand in animal health history with FRONTLINE (Flea and tick product for pets) reaching $1b in annual revenue in 2009.

Prior to working at Merial, Mr. Jactel was Deputy Minister for Economic and Commercial Affairs at the French Embassy in Washington D.C. He is also a recent founder and board member of Hypercell Technologies LLC, an early-stage biotech company developing therapeutic solutions to serious infectious animal disease. Mr. Jactel is a Doctor of Veterinary Medicine and has a Masters in Economic Sciences from the Sorbonne University in Paris. He graduated from the Ecole Nationale d'Administration, Paris in 1993.

Incompetent? Perhaps you have a smarter C.V.?

[maccamcd] 02/1/2015 15:16

White middle aged, grey haired men in suits. Highly dangerous for your wealth.

[corrientes] 02/1/2015 14:40

Just one of an infinite number of AIM companies whose sole purpose is to reward the Board by using share proceeds to enrich themselves. These companies are simply proprietary companies that come up with the wheeze of going on AIM and asking silly potential shareholders for money to boost their pay. The occasional irrelevant RNS will keep them on the right side of the law.

These companies should never be allowed to go on AIM, but then this is corrupt UK plc where anything and everything goes.

[haroldthegreat] 02/12/2014 22:14

have not been asked for vamousse yet . they might have shops stocking it but how many have been sold. they will not get any repeat sales if the initial stock does not sell out! i repeat my original comments that at 16£ a head its too expensive. 4 in the family thats £64 to fork out.

[techair] 02/12/2014 15:49

Yep - just funding Alan and Bruno's wage bill IMHO